Literature DB >> 3000586

Biosynthesis of procalcitonin in small cell carcinoma of the lung.

C C Cate, O S Pettengill, G D Sorenson.   

Abstract

Immunoreactive calcitonin (CT) secreted by DMS 53, a cell line derived from human small cell carcinoma of the lung, consists almost entirely of molecular species larger than the mature hormone (Mr 3,420). Messenger RNA isolated from DMS 53 cells and nude mouse tumors was translated in wheat germ systems, and the products were precipitated with CT-specific antisera. Analyses of the translation products by electrophoresis on 15% polyacrylamide-sodium dodecyl sulfate gels indicated synthesis of a Mr 16,500 preprohormone that was reduced to Mr 14,500 by cotranslation with microsomal membranes. Immunoprecipitation of CT from media from pulse-labeled cultures revealed two major products (Mr 16,500 and Mr 14,500) and up to three minor secreted polypeptides (Mr 9,400, 8,400, and 6,800). Intracellular CT from cell homogenates appeared almost entirely as a single major product (Mr 14,500) and possibly 3-4 minor components (Mr 16,500; 9,200, 8,400, and 6,800). No glycosylated forms of CT were demonstrable by lectin binding methods or labeling attempts with tritiated sugars. The presence of multiple CT species in DMS 53 cells suggests significant post-translational processing of the larger precursor molecules and the accumulation and secretion by small cell carcinoma of the lung of several intermediate immunoreactive forms via a glycosylation-independent secretory pathway.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3000586

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Differential utilization of calcitonin gene regulatory DNA sequences in cultured lines of medullary thyroid carcinoma and small-cell lung carcinoma.

Authors:  A de Bustros; R Y Lee; D Compton; T Y Tsong; S B Baylin; B D Nelkin
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

2.  Serum procalcitonin as a predictor of infectious complications after pancreaticoduodenectomy: review of the literature and our experience.

Authors:  Hiroya Iida; Hiromitsu Maehira; Haruki Mori; Masaji Tani
Journal:  Surg Today       Date:  2019-04-16       Impact factor: 2.549

3.  Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer.

Authors:  M Mabry; T Nakagawa; S Baylin; O Pettengill; G Sorenson; B Nelkin
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116)-peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma.

Authors:  J M Conlon; L Grimelius; L Thim
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

5.  Peptides and growth factors in small cell lung cancer: production, binding sites, and growth effects.

Authors:  G Bepler; M Rotsch; G Jaques; M Haeder; J Heymanns; G Hartogh; P Kiefer; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 6.  Procalcitonin--a new indicator of the systemic response to severe infections.

Authors:  W Karzai; M Oberhoffer; A Meier-Hellmann; K Reinhart
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

7.  Prognostic significance of procalcitonin in small cell lung cancer.

Authors:  Kosuke Ichikawa; Satoshi Watanabe; Satoru Miura; Aya Ohtsubo; Satoshi Shoji; Koichiro Nozaki; Tomohiro Tanaka; Yu Saida; Rie Kondo; Satoshi Hokari; Nobumasa Aoki; Yasuyoshi Ohshima; Toshiyuki Koya; Toshiaki Kikuchi
Journal:  Transl Lung Cancer Res       Date:  2022-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.